Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19
Clinical trial NCT04569383 · COMPLETED
Trial details
- NCT number
- NCT04569383
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2021-08-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.